Neptune & Acasti File Section 337 Complaint on Omega-3 Oil from Krill
Neptune Technologies & Bioresources and its subsidiary Acasti Pharma filed a Section 337 complaint at the International Trade Commission Jan. 29, alleging that ten companies are importing and selling omega-3 extracts that infringe its patents. The products at issue are extracts of omega-3 fatty acids from Antarctic krill. Neptune says the ten companies are infringing on its patents related to the extraction and purification process of the “krill oil.” The company is requesting limited exclusion and cease and desist orders against all respondents. The complaint proposed the following as respondents:
Sign up for a free preview to unlock the rest of this article
Communications Daily is required reading for senior executives at top telecom corporations, law firms, lobbying organizations, associations and government agencies (including the FCC). Join them today!
- Aker BioMarine AS, Norway
- Aker BioMarine Antarctic USA, Inc.
- Aker BioMarine Antarctic AS, Norway
- Enzymotec Limited, Israel
- Enzymotec USA, INC.
- Olympic Seafood AS, Norway
- Olympic Biotec Ltd., New Zealand
- Avoca, Inc., U.S.
- Rimfrost USA, LLC., U.S.
- Bioriginal Food & Science Corp.
Email ITTNews@warren-news.com for a copy of the complaint.
(D/N 2936, Received 01/29/13)